News


  • Dr. Daniel Geschwind, professor of neurology, psychiatry, and genetics, and director of the Neurogenetics Program and the Center for Autism Research at the Semel Institute, was featured by multiple news organizations for his service as co-chairman of a National Institutes of Health committee that made recommendations to the agency regarding the use of chimpanzees in medical research. The committee recommended that the NIH should retire all but 50 of their colony of 360 animals to a national sanctuary. Stories ran Jan. 22 in the Washington Post, Chronicle of Higher Education, Science Magazine, and Nature; Jan.23 in Scientific American, SanAntonio.com, and Care2.com; and Jan. 24 on ABCNews.com and ABC News radio.


  • Dr. Paul Thompson, professor of neurology and a member of the Laboratory of Neuro Imaging (LONI), was featured in the February issue of the French science magazine Science et Vie. The article discussed Thompson's brain mapping work and the ongoing effort to map connections and...

  • Movement Disorders

    NPR Reports on Parkinson's-Pesticide Link

    January 16, 2013

    Dr. Jeff Bronstein, professor of neurology and director of the Movement Disorder Program, was featured in Jan. 15 reports by KQED 88.5FM and KPCC 89.3FM regarding his research that links a pesticide, called Benomyl, to Parkinson's disease. Further, the way Benomyl does its...

  • Movement Disorders

    Media Report on Parkinson's-Pesticide Link

    January 9, 2013

    Dr. Jeff Bronstein, professor of neurology and director of the Movement Disorder Program, was featured widely regarding his research that links a pesticide, called Benomyl, to Parkinson's disease. Coverage included Jan. 3 KCBS-Channel 2 and KCAL-Channel 9 news segments,...

  • Alzheimers Disease

    Media Notes Tribulations of Alzheimer's Clinical Trials

    January 2, 2013

    Joshua Grill, assistant professor of neurology and director of education for the Mary S. Easton Center for Alzheimer's Disease Research, was featured in several outlets regarding his research showing that the outcome of any Alzheimer's clinical trial can be influenced by who...